Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
for Acute Myeloid Leukemia
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18 - 75
Code: NCT06498973·Phase 1·Recruiting·Listed Jul 2024